These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 32209836)

  • 1. Identification of populations likely to benefit from pharmacogenomic testing.
    Heise CW; Gallo T; Curry SC; Woosley RL
    Pharmacogenet Genomics; 2020 Jul; 30(5):91-95. PubMed ID: 32209836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.
    Samwald M; Xu H; Blagec K; Empey PE; Malone DC; Ahmed SM; Ryan P; Hofer S; Boyce RD
    PLoS One; 2016; 11(10):e0164972. PubMed ID: 27764192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.
    Claudio-Campos K; Padrón A; Jerkins G; Nainaparampil J; Nelson R; Martin A; Wiisanen K; Smith DM; Strekalova Y; Marsiske M; Cicali EJ; Cavallari LH; Mathews CA
    Clin Transl Sci; 2021 Mar; 14(2):589-598. PubMed ID: 33166056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
    Fan M; Yarema MC; Box A; Hume S; Aitchison KJ; Bousman CA
    Pharmacogenet Genomics; 2021 Feb; 31(2):29-39. PubMed ID: 32826605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults.
    Chan SL; Ng HY; Sung C; Chan A; Winther MD; Brunham LR; Wee HL
    Pharmacogenomics J; 2019 Aug; 19(4):401-410. PubMed ID: 30250149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing.
    Chan SL; Liew HZW; Nguyen F; Thumboo J; Chow WC; Sung C
    Br J Clin Pharmacol; 2021 Mar; 87(3):886-894. PubMed ID: 32559336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Prescribing and Outcomes After Pharmacogenomic Testing in a Developmental and Behavioral Health Pediatric Clinic.
    Patel JN; Mueller MK; Guffey WJ; Stegman J
    J Dev Behav Pediatr; 2020 Jan; 41(1):65-70. PubMed ID: 31688658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial.
    Olson MC; Maciel A; Gariepy JF; Cullors A; Saldivar JS; Taylor D; Centeno J; Garces JA; Vaishnavi S
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28314093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Many Patients Could Benefit From Pre-emptive Pharmacogenomic Testing and Decision Support? A Retrospective Study Based on Nationwide Austrian Claims Data.
    Kuch W; Rinner C; Gall W; Samwald M
    Stud Health Technol Inform; 2016; 223():253-8. PubMed ID: 27139411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
    Lee YM; Danahey K; Knoebel RW; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):23-30. PubMed ID: 30531378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' Perspectives on Psychiatric Pharmacogenetic Testing.
    Liko I; Lai E; Griffin RJ; Aquilante CL; Lee YM
    Pharmacopsychiatry; 2020 Nov; 53(6):256-261. PubMed ID: 32583391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic.
    Brown JT; MacDonald D; Yapel A; Luczak T; Hanson A; Stenehjem DD
    Pharmacogenomics; 2021 Mar; 22(4):203-212. PubMed ID: 33470873
    [No Abstract]   [Full Text] [Related]  

  • 15. Tracheal Aspirate as an Alternative Biologic Sample for Pharmacogenomics Testing in Mechanically Ventilated Pediatric Patients.
    Hargreaves KA; Pratt VM; Medeiros EB; Lynnes TC; Granfield CA; Skaar TC; Iwata-Otsubo A; Tillman EM
    Clin Transl Sci; 2021 Mar; 14(2):497-501. PubMed ID: 32702149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
    van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VH; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; Swen JJ; Guchelaar HJ;
    Clin Pharmacol Ther; 2017 Mar; 101(3):341-358. PubMed ID: 28027596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal genome testing on physicians improves attitudes on pharmacogenomic approaches.
    Lee KH; Min BJ; Kim JH
    PLoS One; 2019; 14(3):e0213860. PubMed ID: 30921347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
    Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A
    Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.